Indirect Calorimetry Guided Energy Provision in Critically Ill Patients With Obesity
Launched by AUSTRALIAN AND NEW ZEALAND INTENSIVE CARE RESEARCH CENTRE · Sep 21, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The DIRECT trial is a study that aims to find out if a special method called indirect calorimetry can help doctors provide the right amount of energy to critically ill patients who are obese. This method measures how much energy a person's body is using, which can guide nutrition decisions in the Intensive Care Unit (ICU). The trial will include 60 patients who are on mechanical ventilation and are being treated in ICUs across Australia and New Zealand.
To be eligible for this study, participants need to be adults aged 18 and older, have a body mass index (BMI) of 30 or higher, and be between days 3 to 6 of their ICU stay while receiving specific types of nutrition. Patients with major burns, those on certain life-support machines, or with conditions that could make participating unwise will not be included. If they join the study, participants can expect to have their energy needs measured multiple times to help tailor their nutrition during their hospital stay. This trial is currently recruiting participants and aims to improve care for critically ill patients with obesity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (≥ 18 years) patients
- • Body mass index ≥30 kg/m2
- • Between day 3 and 6 of index ICU admission
- • Receiving invasive mechanical ventilation
- • Receiving enteral or parenteral nutrition
- Exclusion Criteria:
- • Receiving extracorporeal membrane oxygenation support
- • Major burns (≥20% total body surface area)
- • Unable to perform indirect calorimetry within 24 hours of randomisation
- • Known pregnancy
- • Death is imminent
- • Treating clinician believes the study is not in the best interest of the patient
About Australian And New Zealand Intensive Care Research Centre
The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) is a leading research organization dedicated to improving outcomes in critically ill patients through innovative clinical trials and research initiatives. Based at Monash University, the Centre fosters collaborative partnerships among clinicians, researchers, and institutions across Australia and New Zealand. Its focus on evidence-based practice and translational research aims to enhance the quality of intensive care, drive advancements in treatment protocols, and ultimately improve patient care in the intensive care unit (ICU) setting. ANZIC-RC is committed to addressing key challenges in critical care medicine, ensuring that findings from its trials contribute to better health outcomes and inform clinical guidelines globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Camperdown, New South Wales, Australia
Ballarat Central, Victoria, Australia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported